Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -86.34 | N/A |
PEG Ratio (TTM) | -1.83 | N/A |
P/S Ratio (TTM) | 0.71 | N/A |
P/B Ratio (TTM) | 2.22 | N/A |
P/FCF Ratio (TTM) | -127.37 | N/A |
Price to 5YR AVG Earnings Ratio | -16.23 | N/A |
Price to 5YR AVG FCF Ratio | -149.29 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.98% | N/A |
ROE (TTM) | -2.54% | N/A |
Net Profit Margin (TTM) | -0.82% | N/A |
ROIC 5YR AVG | -3.51% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -183.65% | -80.73% | -49.92% |
Revenue | 6.13% | -16.75% | -0.23% |
Net Income | -180.48% | -77.85% | -49.44% |
Cash Flow | -0.17% | -49.86% | -109.23% |
Health (46%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.83 | N/A |
Quick Ratio (TTM) | 1.46 | N/A |
D/E Ratio (TTM) | 0.72 | N/A |
Interest Coverage (TTM) | 1.44 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 2.59 | N/A |
LTL to 5YR AVG FCF | -49.22 | N/A |
Shares Outstanding Growth 5YR AVG | 0.50% | N/A |